While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.
Building on clinical data from millions of individuals who received lipid-encapsulated mRNA vaccines, the FDA has issued new guidance that could facilitate a faster transition to first-in-human trials ...
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...
Malaria kills more than a thousand children every day. Measures like antimalarial medications and insecticide-treated bed ...
British scientists are infecting a group of volunteers with a type of malaria that can cause relapses years after contracting it to study its long-term effects. Plasmodium vivax is carried by ...
Serum Institute of India CEO Adar Poonawalla spoke to NDTV on a range of issues, key among them the vaccine for malaria and other mosquito-borne diseases, on the sidelines of the World Economic ...
GlaxoSmithKline (GSK ... It’s not that the Gates Foundation is snubbing malaria vaccines — as one of Gavi’s biggest donors, Gates is helping to fund the R21 rollout. But rather than put ...
We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...
Singapore President Tharman Shanmugaratnam visited the state-of-the-art Sapigen Biologix vaccine facility in Bhubaneswar ...
On the other hand, the malaria vaccine, developed in partnership with pharma giant GSK as part of a technology transfer agreement, will primarily be distributed to low- and middle-income countries ...